rinvoq
(Upadacitinib)AbbVie Inc.
Usage: RINVOQ is indicated for adults and pediatric patients (2+) with various conditions, including moderately to severely active rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn's disease, ankylosing spondylitis, and non-radiographic axial spondyloarthritis, after inadequate response to TNF blockers.